Application 209830

Type
NDA
Sponsor
ALKERMES INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ARISTADA INITIO KITARIPIPRAZOLE LAUROXILSUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR675MG/2.4MLYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
65757-500ARISTADA INITIOaripiprazole lauroxilAlkermes, Inc.NDACurrent
65757-500ARISTADA INITIOaripiprazole lauroxilAlkermes, Inc.NDACurrent
65757-500ARISTADA INITIOaripiprazole lauroxilAlkermes, Inc.NDACurrent
65757-500ARISTADA INITIOaripiprazole lauroxilAlkermes, Inc.NDACurrent
65757-500ARISTADA INITIOaripiprazole lauroxilAlkermes, Inc.NDACurrent
65757-500ARISTADA INITIOaripiprazole lauroxilAlkermes, Inc.NDACurrent
65757-500ARISTADA INITIOaripiprazole lauroxilAlkermes, Inc.NDACurrent
65757-500ARISTADA INITIOaripiprazole lauroxilAlkermes, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
81156SUPPL 2025-02-07
80950SUPPL 2025-02-05
80949SUPPL 2025-02-05
66934SUPPL2021-03-31
64510SUPPL2020-09-04
64509SUPPL2020-09-04
64443SUPPL2020-08-28
59054ORIG2019-06-13
54821ORIG2018-07-06